| Analysis | Metabolite Name | Measured Value | Units | Treatment | Timepoint |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 388108992 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 396605472 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 399350784 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 399468000 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 408022688 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 411013760 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 414295232 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 414508640 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 430142464 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 442125184 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 443855360 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 450072384 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 457538144 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 463935616 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 464371904 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 470241632 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 482893728 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 488199808 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 495914848 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 495969920 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 495991680 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 496429408 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 503952640 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 518240928 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 525764160 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 528215456 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 528255104 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 528901312 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 541887232 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 543643712 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 552370560 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 560231488 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 571177984 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 577870144 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 579129280 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 590137472 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 593220672 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 602238912 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 637219392 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 648275456 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 696108928 | Raw area counts | Usual Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 702976640 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 759911808 | Raw area counts | Enhanced Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 783742592 | Raw area counts | Enhanced Physical Activity | Pre |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 794243264 | Raw area counts | Usual Physical Activity | Post |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 797363200 | Raw area counts | Enhanced Physical Activity | Post |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|